Literature DB >> 18770650

Flow cytometric immunophenotyping of cerebrospinal fluid.

Jaco Kraan1, Jan W Gratama, Corinne Haioun, Alberto Orfao, Anne Plonquet, Anna Porwit, Sandra Quijano, Maryalice Stetler-Stevenson, Dolores Subira, Wyndham Wilson.   

Abstract

Leptomeningeal disease is an important adverse complication occurring in patients with B and T cell lymphomas and acute leukemias of lymphoid and myeloid origin. Recent reports suggest that multiparameter flow cytometry immunophenotypic assessment of spinal fluid samples could improve the efficiency of detection of CNS involvement, due to its high specificity and greater sensitivity. However, spinal fluid samples are frequently paucicellular with a rapidly decreasing cell viability. Staining of spinal fluid therefore requires dedicated sample storage/transport, staining, and preparation protocols. The Basic Protocol in this unit outlines a consensus multiparameter (3- to 8-color) flow cytometry immunophenotypic protocol for the evaluation of CNS involvement of cerebrospinal fluid (CSF) samples by neoplastic cells. A Support Protocol describing the simultaneous assessment of surface and cytoplasmic antigens is also provided. Finally, in the Alternate Protocol, we describe a method to calculate absolute numbers of both normal and pathological cell subpopulations by adding counting beads to the assay.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18770650     DOI: 10.1002/0471142956.cy0625s45

Source DB:  PubMed          Journal:  Curr Protoc Cytom        ISSN: 1934-9297


  19 in total

1.  Flow cytometric immunophenotypic assessment of T-cell clonality by vβ repertoire analysis in fine-needle aspirates and cerebrospinal fluid.

Authors:  Prashant Tembhare; Constance M Yuan; John C Morris; John E Janik; Armando C Filie; Maryalice Stetler-Stevenson
Journal:  Am J Clin Pathol       Date:  2012-02       Impact factor: 2.493

2.  EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes.

Authors:  J J M van Dongen; L Lhermitte; S Böttcher; J Almeida; V H J van der Velden; J Flores-Montero; A Rawstron; V Asnafi; Q Lécrevisse; P Lucio; E Mejstrikova; T Szczepański; T Kalina; R de Tute; M Brüggemann; L Sedek; M Cullen; A W Langerak; A Mendonça; E Macintyre; M Martin-Ayuso; O Hrusak; M B Vidriales; A Orfao
Journal:  Leukemia       Date:  2012-05-03       Impact factor: 11.528

3.  Paradoxical central nervous system immune reconstitution syndrome in acquired immunodeficiency syndrome-related primary central nervous system lymphoma.

Authors:  Sarah M Kranick; Priscila H Goncalves; Maryalice Stetler-Stevenson; Karen Aleman; Mark N Polizzotto; Richard F Little; Robert Yarchoan; Thomas S Uldrick
Journal:  Haematologica       Date:  2014-10-10       Impact factor: 9.941

4.  Detection and outcome of occult leptomeningeal disease in diffuse large B-cell lymphoma and Burkitt lymphoma.

Authors:  Wyndham H Wilson; Jacoline E C Bromberg; Maryalice Stetler-Stevenson; Seth M Steinberg; Lourdes Martin-Martin; Carmen Muñiz; Juan Manuel Sancho; Maria Dolores Caballero; Marjan A Davidis; Rik A Brooimans; Blanca Sanchez-Gonzalez; Antonio Salar; Eva González-Barca; Jose Maria Ribera; Margaret Shovlin; Armando Filie; Kieron Dunleavy; Thomas Mehrling; Michele Spina; Alberto Orfao
Journal:  Haematologica       Date:  2014-04-11       Impact factor: 9.941

5.  Factors associated with survival among patients with AIDS-related primary central nervous system lymphoma.

Authors:  Thomas S Uldrick; Sharon Pipkin; Susan Scheer; Nancy A Hessol
Journal:  AIDS       Date:  2014-01-28       Impact factor: 4.177

Review 6.  Leptomeningeal metastases: a RANO proposal for response criteria.

Authors:  Marc Chamberlain; Larry Junck; Dieta Brandsma; Riccardo Soffietti; Roberta Rudà; Jeffrey Raizer; Willem Boogerd; Sophie Taillibert; Morris D Groves; Emilie Le Rhun; Julie Walker; Martin van den Bent; Patrick Y Wen; Kurt A Jaeckle
Journal:  Neuro Oncol       Date:  2017-04-01       Impact factor: 12.300

7.  Role of flow cytometry immunophenotyping in the diagnosis of leptomeningeal carcinomatosis.

Authors:  Dolores Subirá; Cristina Serrano; Susana Castañón; Raquel Gonzalo; Julia Illán; Javier Pardo; María Martínez-García; Esther Millastre; Francisco Aparisi; Miguel Navarro; Manuel Dómine; Ignacio Gil-Bazo; Pedro Pérez Segura; Miguel Gil; Jordi Bruna
Journal:  Neuro Oncol       Date:  2011-10-12       Impact factor: 12.300

8.  Stabilization media increases recovery in paucicellular cerebrospinal fluid specimens submitted for flow cytometry testing.

Authors:  B Greig; M Stetler-Stevenson; J Lea
Journal:  Cytometry B Clin Cytom       Date:  2013-05-14       Impact factor: 3.058

9.  Flow cytometry increases the sensitivity of detection of leukemia and lymphoma cells in bronchoalveolar lavage specimens.

Authors:  Joo Y Song; Armando C Filie; David Venzon; Maryalice Stetler-Stevenson; Constance M Yuan
Journal:  Cytometry B Clin Cytom       Date:  2012-07-26       Impact factor: 3.058

10.  Cerebrospinal fluid findings in patients with hematologic neoplasms and meningeal infiltration.

Authors:  Renan Barros Domingues; Fernando Brunale Vilela de Moura Leite; Carlos Senne
Journal:  Acta Neurol Belg       Date:  2020-06-10       Impact factor: 2.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.